#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Processing the Hematopoietic Progenitor Grafts andTheir Use in Clinical Practice


Authors: D. Sumerauer;  Š. Matějčková 1;  A. Hrubá 1;  T. Eckschlager
Authors‘ workplace: Klinika dětské onkologie 2. LF UK a FNM, Praha 1ÚHKT, Praha
Published in: Čas. Lék. čes. 2002; : 411-416
Category:

Overview

Autologous stemcell transplantation has been successfully used in treatment of various hematologicalmalignanciesand solid tumors in children and adults. Published data have confirmed that bone marrow harvests and peripheralblood stem cell collections frequently contain a significant number of tumor cells. Contaminating tumor cells cancontribute to the disease relapse in posttransplant period, so attempts are made to eliminate contaminating tumorcells from autografts. In the case of allogenic transplantation, T-lymphocytes depletion from graft decreases the riskof the graft versus host disease after transplantation. In this article we comment techniques available and methodused for elimination of tumor cells. Commentary is aimed on potential benefits and risks of every method.

Key words:
ex vivo purging, bone marrow transplantation, minimal residual disease.

Full text is not available online.
If interested in a scan of this journal, contact NTO ČLS JEP.

Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental Hygienist
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#